Respiratory Drugs and Medications Q 2

---

A pediatric client with asthma has just received omalizumab (Xolair). The nurse determines that the client might be suffering a life-threatening effect in which of the following?

  

     A. Headache and dizziness

     B. Nausea and vomiting

     C. Swelling of the tongue

     D. Joint pain

    

    

Correct Answer: C. Swelling of the lips

---

Omalizumab (Xolair) Xolair is an anti-inflammatory that is used to treat moderate to severe asthma that is caused by allergies. An anaphylactic reaction may happen such as flushing, rash, wheezing, or swelling of the face, lips, or tongue.

---

Options A, B, & D: These are some of the side effects but will not alert the nurse for an anaphylactic reaction.

---